Pfizer reassures Europe over vaccine
PARIS: Pharma giant Pfizer tried to ease concerns in Europe about deliveries of its coronavirus vaccine as nations across the world doubled down on restrictions to fight the rampaging pandemic.
The coronavirus pandemic is showing no signs of slowing down, with infections surging past 94 million and more than two million deaths, and Europe among the hardest-hit parts of the world.
Worries have grown that delays in the delivery of Pfizer-BioNTech shots could hamper a European vaccine rollout which has already faced heavy criticism across the continent.
Work is ongoing at the Pfizer plant in Belgium to increase capacity, and the firm and its German partner BioNTech said Saturday it would allow them to “significantly” scale up vaccine production in the second quarter.
Deliveries would be back to the original schedule to the EU from Jan 25, they pledged.
Several Nordic and Baltic countries have described the situation as “unacceptable”, while Belgium’s vaccination strategy task force condemned a lack of consultation by Pfizer over the deliveries as “incomprehensible”.
